Faralimomab

CAS No: 167816-91-3

Order 167816-91-3

88868-33-1 2(1H)-Pyrimidinone, 1,1'-(1,3-phenylene)bis[tetrahydro-

88867-58-7 Disilanylidyne

88868-64-8 Inosine, 2-octyl-

88867-54-3 Disilene, chlorotrimethyl-

88867-51-0 Disilene, 1,2-dichloro-1,2-dimethyl-, (E)-

88867-35-0 ClH3Si2

88867-36-1 Disilene, 1,1-dichloro-

88868-58-0 7-Octen-1-yn-3-ol, acetate

88868-65-9 Inosine, 2-nonyl-

88868-69-3 Inosine, 2-(2-phenylethenyl)-

88867-57-6 Silylidyne, methyl-

88868-60-4 Bicyclo[5.1.0]oct-2-en-2-ol, acetate

88867-31-6 Disilene, trimethyl-

88868-63-7 Inosine, 2-heptyl-

88867-65-6 N-[(2,2-dimethylpropanoyl)oxy]-N-phenylacetamide

88867-27-0 Disilene, 1,1-dimethyl-

88867-44-1 Disilene, tetrachloro-

88867-48-5 Disilanylidene, 2,2,2-trichloro-1-methyl-

88867-06-5 Silanamine, 1,1-diphenyl-N-(1-phenylethyl)-, (S)-

88868-59-1 Bicyclo[4.1.0]hept-2-en-2-ol, acetate

Order 2438-80-4 6-deoxy-L-Galactose L-(-)-FUCOSE

Order 109-03-5 1,4-Oxathiane 4-oxide

Order 34454-99-4 1,1,2,2,3,3,4,4,4-nonafluoro-N-2-hydroxyethyl-butane-1-sulfonamide

Order 302-95-4 Sodium deoxycholate

167816-91-3 faralimomab,167816-91-3

2025-06-11 Discover Faralimomab (CAS No: 167816-91-3) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.